Stada Arzneimittel AG has ambitions to enter the US consumer health market as it looks to strike out from its European base in search of new opportunities, according to company CEO Peter Goldschmidt. Throughout the world, the German group is keen to strike OTC licensing and partnership deals.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?